Perseus Proteomics, Inc. (JP:4882) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Perseus Proteomics Inc. has reported non-operating income from outsourcing services and faced foreign exchange losses and other expenses in the first half of fiscal year 2025. Additionally, the company recorded significant impairment losses on non-current assets, impacting its financial results for the period.
For further insights into JP:4882 stock, check out TipRanks’ Stock Analysis page.